ISOLATED, SSX-2 AND SSX-2 RELATED PEPTIDES USEFUL AS HLA BINDERS AND CTL EPITOPES, AND USES THEREOF

Details for Australian Patent Application No. 2003261254 (hide)

Event Publications

20 November 2003 Complete Application Filed

Priority application(s): 60/400,076 31.07.02 US

25 March 2004 Application Open to Public Inspection

Published as AU-A-2003261254

26 May 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

25 August 2005 Corrigenda

Applications OPI - Name Index Under the name LUDWIG INSTITUTE FOR CANCER RESEARCH, Application No. 2003261254, under INID (71) correct the name to read TORREY PINES INSTITUTE FOR MOLECULAR STUDIES; LUDWIG INSTITUTE FOR CANCER RESEARCH

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.